---
title: Transhumanism and its sociopolitical impact
videoId: i0oMjqNCgsc
---

From: [[josephnoelwalker]] <br/> 

Transhumanism, at its core, involves human interaction with technology and poses fundamental questions about what aspects of personal identity individuals wish to preserve over time <a class="yt-timestamp" data-t="00:02:10">[00:02:10]</a>. This question is subjective, with no definitive answer from either Eastern or Western philosophy <a class="yt-timestamp" data-t="00:02:21">[00:02:21]</a>.

## Philosophical Implications of Longevity

The discussion on transhumanism often begins with questions of personal identity. For instance, if one rejects the "ego view" of personal identity and instead accepts Derek Parfit's bundle theory—where each individual is a web of experiences shifting through time—it fundamentally impacts how one might approach longevity <a class="yt-timestamp" data-t="00:01:21">[00:01:21]</a>.

Arguments can be made for physical continuity over time, though these reasons may differ significantly from an intuitive "need to survive" <a class="yt-timestamp" data-t="00:02:33">[00:02:33]</a>. The notion of physical continuity, akin to the Ship of Theseus paradox, is often the starting point for many individuals <a class="yt-timestamp" data-t="00:04:39">[00:04:39]</a>. However, deep consideration, similar to Buddhist "no-self" meditation, can lead to the realization that defending strict physical continuity is difficult, bringing philosophical traditions to a similar conclusion as Parfit's view <a class="yt-timestamp" data-t="00:04:42">[00:04:42]</a>.

The "teleporter thought experiment" illustrates different perspectives on identity and preservation:
*   A teleporter creates a copy of you on Mars and destroys the original on Earth <a class="yt-timestamp" data-t="00:09:11">[00:09:11]</a>.
*   Some would use it, others would not <a class="yt-timestamp" data-t="00:09:20">[00:09:20]</a>.
*   Those who would use it might care about preserving their values, a close approximation of their current identity, or simply the continued existence of people similar to themselves <a class="yt-timestamp" data-t="00:09:31">[00:09:31]</a>.
*   In such scenarios, one might feel equally content with the population at large continuing to exist, rather than their specific conscious entity <a class="yt-timestamp" data-t="00:09:59">[00:09:59]</a>.
*   However, even within this view, arguments for longevity can be made, as longer lifespans allow for conscious entities to evolve over extended periods, potentially leading to unseen beauty in conscious experience <a class="yt-timestamp" data-t="00:10:04">[00:10:04]</a>.

These philosophical debates are not merely academic; they subconsciously influence how capital is allocated in fields like longevity, shaping what technologies become available in the future <a class="yt-timestamp" data-t="00:03:07">[00:03:07]</a>.

## Sociopolitical Implications of Longevity

Significant advancements in longevity science, extending human lifespans to 150-200 years, would have profound [[impacts_of_cultural_shifts_on_society | societal impacts]] <a class="yt-timestamp" data-t="00:17:52">[00:17:52]</a>.

### Critiques of Traditional Transhumanism

Traditional transhumanist manifestos are sometimes critiqued for focusing heavily on "gaining power" and "survival," often lacking themes of love or broader human connection <a class="yt-timestamp" data-t="00:11:21">[00:11:21]</a>. This framing is seen as incomplete and overly confident in predicting future technological changes <a class="yt-timestamp" data-t="00:11:44">[00:11:44]</a>. There is a desire for a "humane transhumanism" that is less centered on individual transformation and more on unpredictable [[impacts_of_cultural_shifts_on_society | population-level changes]] <a class="yt-timestamp" data-t="00:11:55">[00:11:55]</a>.

Many science fiction authors intentionally avoid writing futures with qualities vastly different from our own, as such narratives are hard to relate to, leading to a lack of truly new visions for transhumanism <a class="yt-timestamp" data-t="00:13:05">[00:13:05]</a>. Rilke's *Duino Elegies* are suggested as a work that captures a humane transhumanist vision, exploring an individual's attempt to connect with dimly perceived higher levels of understanding or experience, analogous to humans trying to transcend their current state without fully comprehending the transformed future <a class="yt-timestamp" data-t="00:14:27">[00:14:27]</a>.

### Potential Societal Changes with Extended Lifespans

*   **Flourishing of Human Potential**: Extended lifespans could allow individuals to spend their entire lives mastering a craft, potentially leading to unprecedented works of art and knowledge, much like the painter Hokusai, who created "The Great Wave off Kanagawa" in his 60s or 70s and felt he was only just beginning to learn how to draw <a class="yt-timestamp" data-t="00:19:24">[00:19:24]</a>. This suggests that longer lives, coupled with maintained creativity and fluidity, could lead to a deeper evolution of conscious entities <a class="yt-timestamp" data-t="00:20:20">[00:20:20]</a>.
*   **Game Theory and Cooperation**: In game theory, sustained long-term interactions (especially with an unknown number of rounds) incentivize cooperation <a class="yt-timestamp" data-t="00:20:56">[00:20:56]</a>. A society with greatly extended and uncertain lifespans might encourage more pro-social behavior due to the long-term consequences of actions <a class="yt-timestamp" data-t="00:21:28">[00:21:28]</a>.
*   **Inequality**: A significant concern is that the first generation to achieve radical longevity might gain an "insane advantage" due to compounding capital over extended periods <a class="yt-timestamp" data-t="00:22:02">[00:22:02]</a>. This could make being born earlier a new form of inequality, potentially requiring different societal structures or wealth taxation <a class="yt-timestamp" data-t="00:22:16">[00:22:16]</a>. However, the need for continued innovation might mitigate this, as stagnation could lead to being overtaken by those who do innovate <a class="yt-timestamp" data-t="00:22:22">[00:22:22]</a>.
*   **Societal Dynamism and Generational Effects**: Concerns are raised about [[impacts_of_cultural_shifts_on_society | societal dynamism]] if long lifespans mean less turnover in positions and prolonged adherence to worldviews shaped by youthful formative experiences <a class="yt-timestamp" data-t="00:26:10">[00:26:10]</a>. For example, Francis Fukuyama observed that worldviews are often shaped by early life experiences, leading to generational shifts in social and political dimensions <a class="yt-timestamp" data-t="00:26:20">[00:26:20]</a>. While this could lead to a less dynamic society where individuals hold onto outdated beliefs, it is argued that society already adapts through cultural shifts, where new styles and ideas replace older ones, regardless of individual longevity <a class="yt-timestamp" data-t="00:28:05">[00:28:05]</a>.
*   **Scientific Productivity**: Extending the healthy, vigorous, and plastic years of scientists like Einstein for an additional 50 years could yield unimaginable breakthroughs <a class="yt-timestamp" data-t="00:22:46">[00:22:46]</a>. This depends on whether intellectual "stultification" is linked to the aging process or other contingent factors <a class="yt-timestamp" data-t="00:24:04">[00:24:04]</a>. The ability to maintain creative powers over extended periods might require an openness to identity change and the guidance of principles for that change, rather than a rigid preservation of a past self <a class="yt-timestamp" data-t="00:25:24">[00:25:24]</a>.

## Longevity Science and Regulation

The field of longevity medicine views longevity drugs as a type of medicine, similar to exercise or other health-promoting interventions, and argues against irrationally viewing them as fundamentally different <a class="yt-timestamp" data-t="00:07:25">[00:07:25]</a>.

### Challenges in Drug Development
*   **Serendipity**: Drug development often involves serendipitous discoveries, with many drugs being used for purposes other than their original design <a class="yt-timestamp" data-t="00:55:30">[00:55:30]</a>. For longevity drugs, which might need a long time to reveal benefits related to all-cause aging, grappling with serendipity is a challenge <a class="yt-timestamp" data-t="00:56:01">[00:56:01]</a>.
*   **Trial Design**: Running longevity trials is inherently difficult and expensive, requiring very large studies to demonstrate lifespan extension <a class="yt-timestamp" data-t="00:56:50">[00:56:50]</a>. While future advances in biomarkers might provide better proxies for aging and allow for quicker trials, current methods are not sufficient <a class="yt-timestamp" data-t="00:57:29">[00:57:29]</a>.

### Theories of Aging
Aging is a complex phenomenon. While a common assumption is that it's primarily a system breaking down randomly over time, there's a "non-zero component" that appears to be programmed <a class="yt-timestamp" data-t="00:58:49">[00:58:49]</a>. This is considered strange because single gene changes can drastically alter lifespan in many organisms (e.g., C. elegans lifespan can be increased by up to sixfold, mice by around 60%) <a class="yt-timestamp" data-t="00:58:10">[00:58:10]</a>. This suggests that complex biological systems, despite being composed of trillions of atoms, can exhibit surprising sensitivity to simple changes, unlike human-designed systems <a class="yt-timestamp" data-t="00:59:20">[00:59:20]</a>.

### Regulatory Bottlenecks
To reduce regulatory bottlenecks for longevity drugs, an FDA commissioner might:
1.  **Establish Aging as an Indication**: Lay the groundwork to conceptualize and recognize aging as a treatable indication for regulatory purposes <a class="yt-timestamp" data-t="01:01:27">[01:01:27]</a>.
2.  **Shorten Review Timelines**: Drastically reduce review cycles for pre-clinical companies from several months to ideally weeks, while maintaining safety and effectiveness. The current long review times contribute significantly to timeline uncertainty for companies <a class="yt-timestamp" data-t="01:01:44">[01:01:44]</a>.

### Investment in Longevity
Early investments in longevity, such as those by The Longevity Fund, initially focused on "conservative" biotech companies with links to aging, aiming to provide examples that traditional biotech could understand <a class="yt-timestamp" data-t="01:03:09">[01:03:09]</a>. Over time, the focus shifted to "founder-oriented companies going after actual moonshot ideas" from their early stages, which proved to be the most successful pattern <a class="yt-timestamp" data-t="01:03:36">[01:03:36]</a>.

### Cryopreservation as a Longevity Intervention
Cryopreservation, specifically reversible cryopreservation, is seen as a highly impactful and tractable problem that is underworked on <a class="yt-timestamp" data-t="01:09:42">[01:09:42]</a>. It offers a "one-way time machine" to bridge the gap to future therapies for terminal illnesses <a class="yt-timestamp" data-t="01:10:49">[01:10:49]</a>. The ability to pause biological processes, allowing access to future medical advancements, is considered highly leveraged <a class="yt-timestamp" data-t="01:11:50">[01:11:50]</a>.

Technically, cryopreservation is an experimental problem but is amenable to engineering and physics, allowing for deep technological interface <a class="yt-timestamp" data-t="01:12:08">[01:12:08]</a>. The surprising possibility of cryopreserving and rewarming biological entities stems from the fact that cells largely operate on passive diffusion, meaning their internal processes are robust to the randomization of molecular motion that occurs at very low temperatures <a class="yt-timestamp" data-t="01:43:02">[01:43:02]</a>. Unlike human-built machines that rely on deterministic pathways, cells are designed to function amidst thermal noise, making them uniquely "invariant" to such randomization <a class="yt-timestamp" data-t="01:44:04">[01:44:04]</a>. This is a property not typically found in ordinary human-designed objects <a class="yt-timestamp" data-t="01:44:50">[01:44:50]</a>.

Compared to other categories of aging interventions (restoring, replacing, delaying), "pausing" via cryopreservation is considered more straightforward as a single, fully defined problem, offering more direct avenues for physics and engineering solutions <a class="yt-timestamp" data-t="01:13:17">[01:13:17]</a>.

There is a "taboo" or "force field" around cryopreservation, making public communication difficult <a class="yt-timestamp" data-t="01:13:44">[01:13:44]</a>. This anti-mimetic quality, possibly due to it running counter to many human intuitions (e.g., disliking cold), contributes to it being underworked <a class="yt-timestamp" data-t="01:15:59">[01:15:59]</a>.